About Cellanome
Cellanome is a private company based in Foster City, California. It has reported $289,645,170 raised in five offerings on Form D since October 2021. Its chief executive is Omead Ostadan.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 23, 2025 | Jun 22, 2026 | $75,930,476fully sold | 22 | $3.4M | Equity, Series C Preferred StockRule 506(b) | Form D ↗ |
| Dec 4, 2023 | Jan 29, 2024 | $149,999,997fully sold | 20 | $7.4M | Equity, Series B Preferred StockRule 506(b) | Form D ↗ |
| Jul 25, 2022 | Aug 5, 2022amended Mar 21, 2023 | $40,664,711fully sold | 11 | $3.6M | Equity, Series A-2 Preferred StockRule 506(b) | Form D/A ↗1 earlier filing |
| Nov 22, 2021 | Dec 6, 2021 | $20,999,996fully sold | 2 | $10.4M | Series A Preferred StockRule 506(b) | Form D ↗ |
| Sep 17, 2021 | Oct 5, 2021 | $2,049,990fully sold | 17 | $120K | EquityRule 506(b) | Form D ↗ |
| Total, five offerings | $289,645,170 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cellanome's Form D filed Jun 22, 2026.
MK
Mehdi Khodadad
Secretary
Mostafa Ronaghi
Cofounder, Executive Board Member
Also a director at 1health.io Inc.., Clear Labs and Tachin.AI.
Earlier filings also listed Tarun Khurana (executive officer, last listed Jan 2024), Sue McGrath (executive officer, last listed Jan 2024), Ali Agah (executive officer, last listed Jan 2024) and Kazutaka Ohno (executive officer, last listed Mar 2023).